Trends and disparities in the incidence and mortality of stomach cancer in the United States.

Authors

null

Temitope Ajibawo

Multicare Auburn Medical Center, Auburn, WA

Organizations

Multicare Auburn Medical Center, Auburn, WA

Research Funding

No funding sources reported

Background: Stomach cancer is the fifth most common cancer worldwide and has one of the lowest survival rates across all malignancies. There is a constant need to define current stomach cancer incidence and incidence-based mortality (IBM) rates among different population groups for improved clinical practice. We aimed to investigate the trends of stomach cancer incidence and IBM by population characteristics of age groups, gender and ethnic groups. Methods: Data obtained from the National Cancer Institute’s Surveillance, Epidemiology, and End results (SEER) Registry 12 were obtained to determine the incidence and IBM rate of stomach incidence from 1992 to 2020. Joinpoint Regression Analysis program was used to calculate the annual percent change (APC) for trend analysis. Results: A total of 82,810 stomach cancer patients were identified from the dataset. Most of the patients were males; N = 49,909(60.27%) and Non-Hispanic Whites, N = 40,894 (49.38%). The overall incidence rate was 8.00 (95% Confidence Interval [CI]: 7.95 to 8.06) and the overall IBM rate was 6.44 (95%CI: 6.39 to 6.49). The incidence rate of stomach cancer decreased significantly by 1.28 % per year from 1992 to 2020; however the degree of decline from 1992 to 2017, APC (-1.18, 95% CI: -1.27 to -1.04, p < .001) was lower compared to between 2017 and 2020, APC (-3.42, 95% CI: -6.08 to -1.69, p = 0.01). Conversely, IBM rate increased significantly from 1992 to 1994, APC (36.59, 95% CI: 22.51 to 52.29, p < .001) followed by a significant decrease from 1994 to 2020, APC (-1.29, 95%CI: -1.43 to -1.15, p < .001).Incidence rates reduced significantly from 1992 to 2020 for all gender, ethnic and age groups except among the Non-Hispanic Asian Indian or Alaska Native (NHAIAN) population with APC (-0.67, 95 CI% -1.93 to 0.61, p = 0.29) and < 60 years age group with APC (0.03, 95 CI % : 0.18 to 0.25, p = 0.76). Significant decline in IBM rate was observed from 2000 to 2020 across all gender, ethnicities and age groups except among the NHAIAN, APC (-0.21, 95 CI%: -1.26 to 0.84, p = 0.68) and the < 60 years age group, APC (0.16, 95 CI%: -0.33 to -0.65, p = 0.52). Conclusions: Stomach cancer incidence and IBM rates have decreased significantly over the last 20 years except in NHAIAN and < 60 years age populations. These findings suggest the need for further research focused efforts in these potentially high-risk groups.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr e16102)

DOI

10.1200/JCO.2024.42.16_suppl.e16102

Abstract #

e16102

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Differential burdens: A study of gastric cancer hospitalization and outcomes across race and ethnicities.

First Author: Chun-Wei Pan

First Author: Aditya Kumar Ghosh

Abstract

2024 ASCO Annual Meeting

The effect of advances in management of uterine-serous-carcinoma on population mortality.

First Author: Aifen Wang

Abstract

2024 ASCO Annual Meeting

Cancer in Southeast Asia: A comparative analysis of 2022 incidence and mortality data.

First Author: Edward Christopher Christopher Dee